riggered activity arising from early afterdepolarizations (EADs) is considered to be the mechanism responsible for torsade de pointes in patients with the long QT syndrome. 1 In animal experiments, intravenous cesium chloride (Cs) administration produces EADs in the ventricular monophasic action potentials (MAPs) and causes both prolongation of the QT interval and polymorphic ventricular tachycardias (PVTs) resembling torsade de pointes. [2] [3] [4] [5] [6] [7] The electrocardiographic changes and ventricular arrhythmias induced by Cs are considered to represent an experimental animal model of the long QT syndrome. [2] [3] [4] Torsade de pointes associated with the long QT syndrome is often elicited by sudden increases in sympathetic activity 8 and can be suppressed by -adrenergic blocking agents 9 or by ablation of the left stellate ganglion. 10 Isoproterenol infusion prolongs the MAP duration and induces EADs in patients with long QT syndrome. 11 In addition, left stellate stimulation increases the amplitude of EADs induced by Cs and increases the occurrence of ventricular tachycardia (VT) in dogs. 3 Recently, Priori et al reported the differential responses to -adrenergic stimulation in a cellular model of long QT syndrome and suggested that vulnerability to catecholamines may differ in patients with long QT syndrome according to the gene involved. 12 We have shown that vagal stimulation decreases the amplitude of Cs-induced EADs and suppresses the development of PVT. 6 All of these studies emphasize the importance of the autonomic nervous system in the pathogenesis of ventricular arrhythmias in the setting of QT interval prolongation.
Baroreflex sensitivity is a marker of the ability to augment vagal activity. Previous experimental 13 and clinical studies [14] [15] [16] [17] [18] [19] have shown that decreased baroreflex sensitivity is associated with an increased risk of lethal ventricular arrhythmias following myocardial infarction. However, the relationship between baroreflex sensitivity and the risk of ventricular arrhythmias has not been studied in patients with the long QT syndrome or in animal models of Csinduced QT prolongation. The present study was therefore undertaken in rabbits to determine if analysis of baroreflex sensitivity provides predictive information about the induction of ventricular arrhythmias caused by Cs injection.
Methods
All procedures were in keeping with the guidelines of the Physiological Society of Japan concerning the care and use of laboratory animals.
Animal Preparations
Twenty-eight adult male Japanese white rabbits (2.5-3.5 kg) were anesthetized with secobarbital (20mg/kg, intraperitoneal injection) with additional doses administered to maintain a constant level of anesthesia throughout the course of the experiment. An endotracheal tube was inserted, and animals were mechanically ventilated with room air (SN-480-5, Shinano, Tokyo, Japan). Catheters were inserted into the femoral artery for monitoring arterial blood pressure and for obtaining blood samples for the measurement of plasma catecholamine concentrations. Catheters were inserted into the femoral vein for systemic drug administration. After a median sternotomy was performed, the heart was exposed and suspended in a pericardial cradle. Standard ECG (limb lead II), femoral arterial blood pressure and MAPs of the left ventricular endocardium were recorded simultaneously using a multichannel recorder (WT647G, Nihon Kohden, Tokyo, Japan). The rectal temperature was maintained at 38-39°C by a heating pad.
MAP Recordings
The MAP recordings were performed as previously described. 6 A bipolar catheter (3Fr) consisting of a silver-silver chloride electrode with a reference electrode 5 mm from the proximal electrode was introduced through a small stab wound in the left ventricular free wall. The electrode tip was placed on the anterior left ventricular endocardium close to the apical portion of the septum. MAP signals were amplified using an electrophysiologic amplifier (AB-601G, Nihon Kohden) with a frequency range of 0.1 to 10 kHz. The recording site was chosen based on the stability and quality of the signal, using a site that produced an amplitude of at least 15 mV. MAP duration was measured at the levels of 90% repolarization (MAPD90). A delay or a hump formation on the phase 3 repolarization was defined as EAD. The amplitude of EAD was measured as the potential difference between the level of the phase 4 (full repolarization) and the initial departure point from the smooth decay of the phase 3. The EAD amplitude was expressed as a percentage of the total amplitude of MAP.
Experimental Protocol
All experiments were performed during sinus rhythm. Each rabbit was given an intravenous bolus injection of Cs Baroreflex Sensitivity Measurements Baroreflex sensitivity was assessed before median sternotomy, based on the method of Smyth et al. 20 Phenylephrine (7 g/kg) was injected into the femoral vein as a bolus to increase the systolic blood pressure by 15 to 30 mmHg. Baroreflex sensitivity was defined as the slope of the linear regression line relating systolic blood pressure changes to RR interval changes. The phenylephrine injection was repeated twice, at least 5 min apart, and the average of the 2 measurements was used as the value for baroreflex sensitivity. Only regression lines having a significant (p<0.05) correlation coefficient were used for analysis.
Catecholamine Measurements To measure the plasma concentration of norepinephrine, arterial blood was obtained just before the first Cs injection (baseline) and 20 min after the last Cs injection (post-Cs). The plasma norepinephrine concentration was determined by high performance liquid chromatography using electrochemical detection.
Definition of Ventricular Arrhythmias
The following definitions were used for the ventricular arrhythmias recorded by ECG: (1) simple ventricular premature contractions (VPCs), single or coupled VPCs; (2) VT, 3 or more consecutive VPCs; (3) polymorphic VT (PVT), irregular VT with varying QRS morphologies; and (4) monomorphic VT (MVT), regular VT with a single morphology.
Statistical Analysis
All measurements are expressed as the mean ± SEM. Statistical analyses were performed using ANOVA with Fisher's PLSD test or Student's paired t test. Linear regression analysis was used to assess the relationship between baroreflex sensitivity and plasma norepinephrine concentration. A p value less than 0.05 was considered to indicate a significant difference.
Results

Characteristics of Ventricular Arrhythmias Induced by Cs Injections
Before the first Cs injection, none of the rabbits had ventricular arrhythmias, and all MAPs had smooth repolarizations with no evidence of EAD (Fig 1A) . The 3 Cs injections consistently induced EADs (Fig 1B, arrows) caused ventricular arrhythmias in most animals. The characteristics of the Cs-induced ventricular arrhythmias varied between rabbits and between the 3 consecutive Cs injections ( Table 1 ). The first injection produced simple VPCs in 11 of the 28 rabbits, but did not cause VT. The second injection produced simple VPCs in 10 rabbits, MVT in 4 rabbits and PVT in 4 rabbits. In 2 animals (no. 21 and 22), MVT eventually degenerated into ventricular fibrillation. Therefore, the third Cs injection was not given in these rabbits. The third Cs injection produced simple VPCs in 4 of the remaining 26 rabbits, MVT in 3 rabbits and PVT in 4 rabbits. In one animal with MVT (no. 23) and one with PVT (no. 25), VT degenerated into ventricular fibrillation. The characteristics of PVT and MVT differed in several important aspects. First, PVT occurred when the EAD increased above a certain amplitude and the take-off potential of the premature action potential was very close to the peak amplitude of the EAD (Fig 2A) , whereas the repetitive MAPs during MVT arose from the level of phase 4 ( Fig 2B) . Second, the development of PVT was always preceded by a long RR interval (Fig 2A) , but this phenomenon was not observed in MVT (Fig 2B) .
Based on the ventricular arrhythmias induced by the 3 Cs injections, rabbits were divided into 4 groups ( Table 1) : (1) no ventricular arrhythmic response to all 3 Cs injections (seen in 5 rabbits; No-VPC group), (2) Cs injection produced simple VPCs, but not VT (13 rabbits; VPC group), (3) MVT induced by at least one Cs injection (5 rabbits; MVT group) and (4) PVT induced by at least one Cs injection (4 rabbits; PVT group). In one rabbit (no. 28), both MVT and PVT were induced. Inclusion of this rabbit into either the PVT group or the MVT group, or its exclusion from both groups made no significant difference in the analysis of baroreflex sensitivity or plasma norepinephrine concentration. Accordingly, this rabbit was excluded from the following analysis for the simplicity of description. Table 2 shows a comparison of the baseline value of MAPD90, Cs-induced change of MAPD90 (∆MAPD90) and RR interval (∆RR), and EAD amplitude. MAPD90 showed no significant differences between the groups. ∆MAPD90 was significantly smaller in the MVT group than in the No-VPC group. ∆RR and EAD amplitude were significantly greater in the PVT group than in the other groups.
Baroreflex Sensitivity
No significant differences were noted in the baseline values for the RR interval or the systolic and diastolic blood pressures between the groups. Fig 3 shows the baroreflex sensitivity at baseline for the 4 groups. Baroreflex sensitivity was significantly lower in the MVT group (0.23±0.10 ms/mmHg) than in the No-VPC group (0.56±0.09 ms/mmHg, p<0.05) and the VPC group (0.49± 0.06 ms/mmHg, p<0.05). Baroreflex sensitivity in the PVT group (0.26±0.06 ms/mmHg) was significantly lower than in the No-VPC group (p<0.05), and tended to be lower than in the VPC group (p=0.059). No significant differences were observed in the baroreflex sensitivity between the No-VPC and the VPC groups or between the MVT and the PVT groups.
Plasma Norepinephrine Concentration
Fig 4 summarizes the plasma norepinephrine concentration during the baseline (A) and post-Cs period (B) for the 4 groups. At baseline, the MVT group had a significantly higher norepinephrine concentration (944.0±189.9 pg/ml) than the No-VPC group (382.0±89.5 pg/ml, p<0.01), the VPC group (556.7±64.2 pg/ml, p<0.05), and the PVT group (523.0±110.3 pg/ml, p<0.05). The injection of Cs produced a significant increase in the norepinephrine concentration in all groups (p<0.0001). However, the postCs norepinephrine concentration was significantly higher in the MVT group (8964.0±1904.6 pg/ml) than in the No-VPC group (1959.8±961.0 pg/ml, p<0.001) and the VPC group (1867.7±224.8 pg/ml, p<0.0001). The PVT group also had a significantly higher post-Cs norepinephrine concentration (5900.0±2147.3 pg/ml) than the No-VPC group (p<0.05) and the VPC group (p<0.05). The post-Cs norepinephrine concentrations were similar between the MVT and PVT groups. The baroreflex sensitivity and plasma norepinephrine concentration measured at baseline were negatively correlated (r=0.50, p<0.01; Fig 5) .
Discussion
In this study, rabbits received 3 intravenous injections of Cs at 20 min intervals, which induced EADs in all of the rabbits. However, the ventricular arrhythmias induced by Cs differed between the animals. The animals could be grouped according to the type of induced ventricular arrhythmias.
Baroreflex Sensitivity and Plasma Norepinephrine Concentration
The present study revealed that the MVT and PVT groups had decreased baseline baroreflex sensitivity compared with the No-VPC and VPC groups. Previous animal experiments 13 and clinical studies [14] [15] [16] [17] [18] [19] have shown that depressed baroreflex sensitivity predicts an increased risk of lethal ventricular arrhythmias following myocardial infarction. The pathogenesis of the long QT syndrome and the occurrence of torsade de pointes also are strongly associated with autonomic activity. [8] [9] [10] [11] However, to our knowledge, no study has addressed the prognostic value of baroreflex sensitivity in patients with long QT syndrome. The present study demonstrated that decreased baroreflex sensitivity predicts the induction of VT by intravenous Cs injection. Decreased baroreflex sensitivity reflects reduced vagal activity combined with increased sympathetic activ- Table 1 .) *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; † p<0.0001 vs the value before the first cesium injection. Relationship between the plasma norepinephrine concentration and baroreflex sensitivity measured before the first cesium injections. A significant negative correlation was found between the 2 parameters. Table 1 .) *p<0.05.
ity. We found an inverse relationship between baroreflex sensitivity and plasma norepinephrine concentration, which is consistent with the relationship reported by Goldstein. 21 The baseline plasma norepinephrine concentration in the MVT group was higher than in the No-VPC, VPC and PVT groups. Although Cs injection increased the plasma concentration of norepinephrine in all 4 groups, the increase was greater in the PVT and MVT groups than in the No-VPC and VPC groups. Cs has been shown to induce the release of catecholamines. 22 The increase in the plasma norepinephrine concentration in the MVT and PVT groups might be either a cause of VT or consequence of hemodynamic changes due to ventricular tachyarrhythmias, or both.
Mechanism of Cs-induced Ventricular Arrhythmias
The present findings, and our previous studies, 6 ,23 suggest that PVT is caused by EADs, whereas MVT is caused by a different mechanism. We have previously reported that MVT is increased by rapid pacing and that this type of VT is possibly due to either low membrane potential automaticity or triggered activity arising from delayed afterdepolarizations (DADs). 23 Nayebpour et al observed that Cs-induced VT in dogs rarely has the morphologic features of torsade de pointes. 5 These previous observations, [5] [6] [7] 23 as well as those of the present study, suggest that not all ventricular arrhythmias induced by Cs are caused by EADs.
In the present study, the PVT and MVT groups had decreased baroreflex sensitivity and the MVT group had an increased plasma norepinephrine concentration compared with the No-VPC and VPC groups. It has been well documented that decreased vagal activity and increased sympathetic activity accelerate the development of ventricular tachyarrhythmias in the setting of long QT syndrome, [8] [9] [10] [11] as well as in the setting of myocardial ischemia or infarction. [14] [15] [16] Cs induces EADs by inhibiting the inward rectifying potassium current. 24 In addition, 2 other actions of Cs can affect the induction of either PVT or MVT: slowing of the sinus node, and release of norepinephrine. Cs induces sinus slowing, which enhances EADs and PVT, but not MVT. 6, 23 Indeed, in the present study the development of PVT was always preceded by a pause. In contrast, we have previously reported that MVT is enhanced by rapid pacing. 23 Cs induces the release of catecholamines both centrally and peripherally. 22 Catecholamines potentiate all of the main electrophysiologic phenomena underlying arrhythmogenesis: increased automaticity, triggered activity due to EADs or DADs, and reentry. 25, 26 However, increased catecholamine concentrations also increase heart rate, which may decrease the EAD amplitude and thereby suppress PVT. Therefore, although catecholamines can enhance both PVT and MVT, they are more likely to enhance MVT. This hypothesis is consistent with the present finding that the plasma norepinephrine concentration was greater in the MVT group than in the PVT group.
Study Limitations
In the present study, baroreflex sensitivity and plasma norepinephrine concentrations were assessed in anesthetized animals. Anesthesia can affect the autonomic nervous system and cardiovascular hemodynamic responses, including heart rate, blood pressure and baroreflex sensitivity. 27, 28 Halliwill and Billman have reported that baroreflex sensitivity decreased during pentobarbital anesthesia. 28 Secobarbital used here may have similar effects. Although the values for baroreflex sensitivity in this study are smaller than those reported in conscious humans, they are consistent with values reported in anesthetized rabbits. 27 
Clinical Implications
The arrhythmias induced by Cs have been considered an experimental model for the arrhythmias in patients with long QT syndrome. The present study demonstrated that the presence of decreased baroreflex sensitivity is associated with a greater susceptibility to VT during intravenous Cs administration. It suggests that baroreflex sensitivity may predict the risk of malignant ventricular arrhythmias in patients with long QT syndrome. However, further studies are required in the human clinical setting.
